Abstract
Depressive episodes are more common and last longer in patients with bipolar disorder relative to manic or hypomanic episodes. They are often refractory to current pharmacologic treatment strategies, resulting in increased morbidity and mortality. There has been increased interest in neuromodulatory treatments, namely repetitive transcranial magnetic stimulation (rTMS) for treating bipolar depression, given its proven efficacy in unipolar depression. This review seeks to summarize the current evidence regarding the efficacy of rTMS for the treatment of depression in bipolar disorder, identify limitations, and provide suggestions for future research on the use of rTMS in the treatment of bipolar depression. [ Psychiatr Ann . 2023;53(2):68–72.]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
